Literature DB >> 33285272

Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study.

Yi Ji1, Siyuan Chen2, Kaiying Yang3, Bo Xiang3, Xian Jiang4, Xuewen Xu5, Lizhi Li6, Tong Qiu3, Jiangyuan Zhou3, Shiyi Dai3, Xuepeng Zhang7, Guoyan Lu8, Feiteng Kong9, Gang Yang10, Qingxia Qiu11.   

Abstract

BACKGROUND: Abdominal ultrasonography has been proposed to screen for infantile hepatic hemangioma (IHH) in patients with multiple cutaneous infantile hemangiomas (IHs).
OBJECTIVES: The aim of this study was to establish the optimal cutoff point for the number of cutaneous IHs needed to screen for IHH.
METHODS: We performed a prospective, multicenter study to screen for IHH in patients younger than 9 months who had multiple cutaneous IHs (n ≥ 3) on ultrasonography. For comparison, a group of patients with 1 or 2 focal cutaneous IHs was also recruited.
RESULTS: In total, 676 patients with at least 3 cutaneous IHs and 980 patients with 1 or 2 focal cutaneous IHs were enrolled. Thirty-one patients were found to have IHH. A higher number of cutaneous IHs was associated with an increased risk of IHH (R = 0.973; P < .001). Receiver operating characteristic curve analysis showed that 5 cutaneous IHs was the optimal cutoff point to screen for IHH, with an area under the curve of 0.872 (P < .001; 95% confidence interval, 0.789-0.955). LIMITATIONS: This was an uncontrolled study.
CONCLUSIONS: Screening for IHH is recommended in patients younger than 9 months who present with 5 or more cutaneous IHs.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cutoff point; infantile hemangioma; infantile hepatic hemangioma; multiple; screening

Year:  2020        PMID: 33285272     DOI: 10.1016/j.jaad.2020.11.062

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma.

Authors:  Liang Wang; Jing Li; Dan Song; Lei Guo
Journal:  Pediatr Surg Int       Date:  2022-06-16       Impact factor: 1.827

Review 2.  Medical Management of Infantile Hemangiomas: An Update.

Authors:  Caroline Colmant; Julie Powell
Journal:  Paediatr Drugs       Date:  2021-10-22       Impact factor: 3.022

Review 3.  Infantile hepatic hemangiomas: looking backwards and forwards.

Authors:  Xue Gong; Yanan Li; Kaiying Yang; Siyuan Chen; Yi Ji
Journal:  Precis Clin Med       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.